Literature DB >> 16245243

Management of hypertension in chronic kidney disease: the Italian multicentric study.

L De Nicola1, R Minutolo, C Gallo, C Zoccali, B Cianciaruso, Marilena Conte, A Lupo, G Fuiano, Mario Gallucci, M Bonomini, P Chiodini, G Signoriello, V Bellizzi, F Mallamaci, Felice Nappi, G Conte.   

Abstract

BACKGROUND: Guidelines have indicated the achievement of blood pressure target (BP <130/80 mmHg) as a priority in the conservative treatment of chronic kidney disease (CKD), but the current implementation of these recommendations in clinical practice is unknown.
METHODS: We assessed control rates, treatment and clinical correlates of hypertension in 1201 adult non-dialyzed CKD patients followed up by a nephrologist for at least 6 months.
RESULTS: Estimated glomerular filtration rate (GFR) was 32 (SD 15) mL/min/1.73 m2. BP target was not achieved in 88% of patients (95% confidence interval (95% CI): 86-90%). In 84% of patients, BP levels were also above the target at the first visit to the nephrology unit 4.5 yrs previously. The risk of not achieving BP target during the nephro-logy follow-up was associated with older age (odds ratio (OR): 1.24, 95% CI 1.06-1.45, p=0.008), diabetes (OR: 2.25, 95% CI 1.20-4.20, p=0.011), and the duration of hypertension (OR: 1.13, 95% CI 1.02-1.24, p=0.016). Among patients with uncontrolled BP, about 70% received multidrug antihypertensive therapy including renin-angiotensin system (RAS) inhibitors; conversely, diuretic treatment was prescribed in a minority of patients (37%), and at insufficient doses in half the cases, despite the insufficient implementation of a low salt diet (18%).
CONCLUSIONS: BP target was not reached in most CKD patients routinely seen in the renal clinics. The main barrier to guideline implementation is possibly the inadequate treatment of extracellular volume expansion despite the large prevalence of factors, such as older age and diabetes, which further enhance the intrinsic BP salt sensitivity of CKD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16245243

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Hypertension and progression of nephropathy in diabetic and non-diabetic chronic kidney disease patients.

Authors:  O Stojceva-Taneva; G Selim; L Stojkovski; N Ivanovski
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

2.  Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.

Authors:  Sabelo Bonginkosi Dlamini; Ming-Tsang Wu; Hans-Uwe Dahms
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

3.  Resistant hypertension in nondialysis chronic kidney disease.

Authors:  Silvio Borrelli; Luca De Nicola; Giovanna Stanzione; Giuseppe Conte; Roberto Minutolo
Journal:  Int J Hypertens       Date:  2013-04-22       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.